Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Stram

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Cancer|December 18, 2001
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer GroupH Shimada, S Umehara, Y Monobe, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group StudyE Rudnick, Y Khakoo, N L Antunes, et al.
American Journal of Epidemiology|November 5, 1997
Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study GroupE A Operskalski, D O Stram, M P Busch, et al.
Cancer|January 1, 1994
Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. A report from the Childrens Cancer GroupJ Z Finklestein, D R Miller, J Feusner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group studyC A Perez, K K Matthay, J B Atkinson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group resultsK K Matthay, M C O'Leary, N K Ramsay, et al.
Transfusion|September 1, 1996
Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomesJ W Mosley, W Huang, D O Stram, et al.
The Journal of Infectious Diseases|July 1, 1996
Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study GroupM P Busch, E A Operskalski, J W Mosley, et al.
Progress in Clinical and Biological Research|January 1, 1994
Comparison of autologous and allogeneic bone marrow transplantation for neuroblastomaK K Matthay, R C Seeger, C P Reynolds, et al.
The Journal of Infectious Diseases|September 1, 1995
Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study GroupE A Operskalski, D O Stram, H Lee, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Cancer|December 18, 2001
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer GroupH Shimada, S Umehara, Y Monobe, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group StudyE Rudnick, Y Khakoo, N L Antunes, et al.
American Journal of Epidemiology|November 5, 1997
Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study GroupE A Operskalski, D O Stram, M P Busch, et al.
Cancer|January 1, 1994
Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. A report from the Childrens Cancer GroupJ Z Finklestein, D R Miller, J Feusner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group studyC A Perez, K K Matthay, J B Atkinson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group resultsK K Matthay, M C O'Leary, N K Ramsay, et al.
Transfusion|September 1, 1996
Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomesJ W Mosley, W Huang, D O Stram, et al.
The Journal of Infectious Diseases|July 1, 1996
Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study GroupM P Busch, E A Operskalski, J W Mosley, et al.
Progress in Clinical and Biological Research|January 1, 1994
Comparison of autologous and allogeneic bone marrow transplantation for neuroblastomaK K Matthay, R C Seeger, C P Reynolds, et al.
The Journal of Infectious Diseases|September 1, 1995
Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study GroupE A Operskalski, D O Stram, H Lee, et al.
Pageof 9